LITS
Lite Strategy, Inc.
NASDAQ: LITS · HEALTHCARE · BIOTECHNOLOGY
$1.15
+0.00% today
Updated 2026-04-30
Market cap
$42.54M
P/E ratio
—
P/S ratio
0.31x
EPS (TTM)
$-1.82
Dividend yield
—
52W range
$1 – $8
Volume
0.3M
Lite Strategy, Inc. (LITS) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating cash flow | $-31.96M | $-48.75M | $-52.48M | $-50.47M | $-20.84M |
| Capital expenditures | $707999.00 | $479000.00 | $35000.00 | $7000.00 | $0.00 |
| Depreciation | — | — | — | — | — |
| Stock-based comp | $10.24M | $8.35M | $3.59M | $2.28M | $-144000.00 |
| Free cash flow | $-32.67M | $-49.23M | $-52.52M | $-50.48M | $-20.84M |
| Investing cash flow | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — |
| Dividends paid | — | — | $0.00 | $11.66M | $0.00 |
| Share repurchases | — | — | — | — | — |
| Debt repayment | — | — | — | — | — |
| Net change in cash | — | — | — | — | — |